Workman Lauren, Fang Lauren, Blazevic Martina, Chen Joanna, Simman Richard
College of Medicine and Life Sciences, University of Toledo, 3000 Arlington Ave, Toledo, OH, 43614, USA.
College of Medicine and Life Sciences, Division of Plastic and Reconstructive Surgery, University of Toledo, 3000 Arlington Ave, Toledo, OH, 43614, USA.
J Med Case Rep. 2024 Dec 31;18(1):647. doi: 10.1186/s13256-024-04908-2.
Although rare, melanoma confined to the dermis or subcutaneous tissue without evidence of a primary cutaneous site should provoke consideration of melanoma of unknown primary. This diagnosis carries a favorable prognosis when compared with cutaneous metastatic melanoma. Several hypotheses have been proposed for how melanoma of unknown primary develops, two of which were considered in our patient case: (1) spontaneous regression of the primary tumor following metastasis or (2) the traumatic implantation of ectopic melanocytic cells in other tissues, such as the subcutaneous tissue. Although not a true example of melanoma of unknown primary, our case is still noteworthy as it represents a unique instance of melanoma presenting subcutaneously from trauma to a preexisting epidermal nevus.
We present the case of a 66-year-old non-Hispanic Caucasian male who initially sought evaluation for a nontender lump of the left groin. Ultrasound-guided needle biopsy demonstrated stage III malignant melanoma. Upon further history taking, it was discovered that he had a nevus of the left medial ankle that was subjected to traumatic removal. He later developed a subcutaneous nodule at the same site. Positron emission tomography scan results supported the histopathologic findings which demonstrated invasive melanoma centered in the subcutaneous tissue without an epidermal component. Following left inguinal lymph node dissection, the patient received adjuvant immunotherapy and radiation to the left inguinal area. At 6 months following completion of therapy, metastases were identified in the lungs, vertebra, ribs, and liver. The patient is currently receiving immunotherapy with ipilimumab-nivolumab.
As our patient did not have a readily apparent primary epidermal melanoma site at presentation, consideration was given as to whether this case may represent a melanoma of unknown primary, as originally defined by Das Gupta. This case does not meet the proposed criteria, however, as the patient reported a preexisting nevus in the area that was subjected to traumatic removal. Instead, we postulate that this trauma allowed for implantation of melanocytes into the subcutaneous tissue that later resulted in a malignant melanoma.
虽然罕见,但局限于真皮或皮下组织且无原发性皮肤部位证据的黑色素瘤应引发对原发性不明黑色素瘤的考虑。与皮肤转移性黑色素瘤相比,该诊断预后较好。关于原发性不明黑色素瘤的发生提出了几种假说,我们的病例考虑了其中两种:(1)转移后原发性肿瘤自发消退;(2)异位黑素细胞在其他组织(如皮下组织)中的创伤性植入。虽然我们的病例并非原发性不明黑色素瘤的真实例子,但仍值得注意,因为它代表了一种独特的情况,即黑色素瘤由先前存在的表皮痣受创伤后在皮下出现。
我们报告一例66岁非西班牙裔白人男性,最初因左腹股沟无痛性肿块寻求评估。超声引导下针吸活检显示为III期恶性黑色素瘤。进一步询问病史发现,他左内踝有一痣,已接受创伤性切除。后来在同一部位出现皮下结节。正电子发射断层扫描结果支持组织病理学发现,显示侵袭性黑色素瘤以皮下组织为中心,无表皮成分。左腹股沟淋巴结清扫术后,患者接受了辅助免疫治疗和左腹股沟区放疗。治疗完成6个月后,在肺、椎骨、肋骨和肝脏发现转移灶。患者目前正在接受伊匹木单抗-纳武单抗免疫治疗。
由于我们的患者就诊时没有明显的原发性表皮黑色素瘤部位,因此考虑该病例是否可能代表最初由达斯·古普塔定义的原发性不明黑色素瘤。然而,该病例不符合提议的标准,因为患者报告该区域先前存在痣且已接受创伤性切除。相反,我们推测这种创伤使黑素细胞植入皮下组织,随后导致恶性黑色素瘤。